Ep 63: Enrico Baraldi & antibiotics' markets. Colonization of the microbiome. 2025 GLASS report.

About this episode

The episode discusses the complexities of antibiotic markets and the factors influencing the colonization of the microbiome by antibiotic-resistant bacteria.

We hear a lot about the need for new antibiotics. But what about the ones we already have? In this episode, we sit down with Enrico Baraldi to explore the hidden world behind antibiotic markets. You hear how supply chains break, why withdrawals happen, and what it really takes to keep essential drugs available in countries like Sweden. You also get a look at the methods behind this research, the collaborations that make it possible, and some misconceptions that still shape the policy conversation. What happens when economic models, healthcare needs, and global responsibilities collide? This conversation opens that door. On our news section, we first cover a recent publication exploring the factors determining the colonization of the microbiome by antibiotic-resistant E. coli bacteria, and we bring an overview of the much-awaited Global Antibiotic Resistance Surveillance Report for 2025. We wish you a peaceful and rewarding winter break, and see you again in the new year! Check relevant links in the show notes here . ⁠ Follow our updates on ⁠twitter/X & Bluesky⁠ with #theAMRstudio hashtag! Theme music by ⁠Henrik Niss⁠ .

People in this episode

Guest: Enrico Baraldi

Topics covered

• antibiotic markets
• microbiome colonization
• supply chains
• healthcare policy
• antibiotic resistance
• economic models

Keywords

• antibiotics
• microbiome
• E. coli
• supply chains
• healthcare
• policy
• antibiotic resistance
• GLASS report

Mentioned in this episode

Organizations: Uppsala Antibiotic Center, Global Antibiotic Resistance Surveillance Report

Products: antibiotics

Places: Sweden